On Friday, NYSE UNP opened at $198.64 which is relatively lower compared to its year highs and lows for the past twelve months as indicated below: The details about this transaction were disclosed through a regulatory filing with SEC accessible via hyperlink.

As a result, Whited now owns 39,080 worth $8,324,040 of Union Pacific’s common stock after the completion of this transaction. Whited has recently sold 2,500 shares of the company’s stock on February 27th at an average price of $213.00. In other news related to Union Pacific Co., executive vice president Elizabeth F. Though Community Trust & Investment Co.’s holdings in Union Pacific amounted to $2,699,000 when the SEC filing was made, this is a drop from its previous investment amount. The institutional investor had owned 13,035 shares of the railroad operator’s stock, which decreased following the sale of 3,586 shares. by 21.6% in the fourth quarter, according to its latest Securities and Exchange Commission (SEC) filing. has reduced its holdings in Union Pacific Co. He is a graduate of Xavier University, a former bank manager and credit analyst, and a former Fidelity Investments registered investment representative.Community Trust & Investment Co. Cotton is publisher of the market newsletter, Cotton’s Technically Speaking. For Investment Advice consult a Registered Investment Advisor or a Certified Financial Planner. This article is not investment advice, nor is it in any way to be construed as investment advice. His 2020 Wall Street’s Best stock contest winner was Inovio Pharmaceuticals (Symbol INO) with a 742% 1-Year return. Joe Cotton has won three National Stock Picking Contests with yearly percentage gains in excess of 96%. For Investment Advice consult a Registered Investment Advisor or Certified Financial Planner. It is not investment advice, nor is it in any way to be construed as Investment Advice.

The above is my personal opinion and it is based primarily on the analysis of SAVA’s stock chart. If it is a short squeeze, the stock could get back to $100 in a very short timeframe, and if the FDA approves their Alzheimer’s drug, we would expect the stock to go to $300 or more.Ĭassava Sciences (SAVA) is a VERY SPECULATIVE STOCK – Meaning that you are in essence “gambling” if you buy it, because you could lose part or all of your investment.

16, 2022, reported that SAVA stock soared after it was disclosed that board member and well known investor, Sanford Robertson, just bought 100,000 shares of the stock, worth over $2 Million. Secondly, reports that there are only 40.1 Million shares outstanding, and only a Float of 37.4 Million shares, and 11.43 Million shares sold Short, as of July 29, 2022, which is equal to 30.20% of the FLOAT….which is a HUGE percentage for such a thinly traded stock.Īnd thirdly, on Aug. Some skeptics say that the company manipulated the data, but we personally don’t believe it. We bought it last week, and think it is a prime candidate for a short squeeze.įirst of all, Cassava has a drug in 3rd Phase trials that seems to have the potential to actually improve the cognition of Alzheimer’s patients, not just slow the progression of the disease. Wednesday, it is already up $2.63 from yesterday’s close of $25.31, see chart below. The stock we are featuring today is Cassava Sciences (SAVA). However, there are still great opportunities to make lots of money…especially buying stocks that are in a short squeeze. Lots of money was made by the traders with courage and brains. The Market (The DOW) is now up about 158 points at 12:11p.m., a great needed rally after it fell about 900 points in the last 3 days.Īs we wrote on July 4th, we continue to maintain that the Bear Market ended a couple of months ago. Market Assessment – As of Wednesday, August 24 at 12:11 p.m.

Sava yahoo finance